Michelle Slade, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 560 Tavern Hill Rd, Jonesborough, TN 37659 Phone: 423-676-1522 |
News Archive
Various medications have been developed to treat neurodegenerative disorders, and drugs without significant side effects are gaining widespread interest such disorders.
By examining very small differences in people's genes, scientists from Cornell University have developed a new tool for identifying big events in human history and pinpointing the origins of specific gene mutations.
Christian Lienhardt of the Stop TB Partnership and colleagues examine the research necessary to stop tuberculosis (TB) and introduce the TB Research Movement, which aims to "boost TB research and accelerate progress in TB control towards international targets," in this PLoS Medicine article.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
› Verified 4 days ago